Gene · 652995
Papers3,485
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,001 to 1,020 of 3,485
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Inferring Latent Disease-lncRNA Associations by Label-Propagation Algorithm and Random Projection on a Heterogeneous Network. | Front Genet | 2022 | 35186029 | PubTator, text mining | PubMed |
| LncRNA SND1-IT1 facilitates TGF-β1-induced epithelial-to-mesenchymal transition via miR-124/COL4A1 axis in gastric cancer. | Cell Death Discov | 2022 | 35184134 | PubTator, text mining | PubMed |
| Comment on 'Long noncoding RNA UCA1 promotes glutamine-driven anaplerosis of bladder cancer by interacting with hnRNP I/L to upregulate GPT2 expression' by Chen et al.'". | Transl Oncol | 2022 | 35182956 | PubTator, text mining | PubMed |
| LncRNA UCA1 Promotes the Progression of AML by Upregulating the Expression of CXCR4 and CYP1B1 by Affecting the Stability of METTL14. | J Oncol | 2022 | 35178087 | PubTator, text mining | PubMed |
| Hypoxic pancreatic cancer derived exosomal miR-30b-5p promotes tumor angiogenesis by inhibiting GJA1 expression. | Int J Biol Sci | 2022 | 35173549 | PubTator, text mining | PubMed |
| ZNF204P is a stemness-associated oncogenic long non-coding RNA in hepatocellular carcinoma. | BMB Rep | 2022 | 35168700 | PubTator, text mining | PubMed |
| Exosomes derived from M2 type tumor-associated macrophages promote osimertinib resistance in non-small cell lung cancer through MSTRG.292666.16-miR-6836-5p-MAPK8IP3 axis. | Cancer Cell Int | 2022 | 35168607 | PubTator, text mining | PubMed |
| Identification and validation of a twelve immune infiltration-related lncRNA prognostic signature for bladder cancer. | Aging (Albany NY) | 2022 | 35165206 | PubTator, text mining | PubMed |
| The Role of Exosomal Non-Coding RNAs in Colorectal Cancer Drug Resistance. | Int J Mol Sci | 2022 | 35163397 | PubTator, text mining | PubMed |
| Regulation of LncRNAs in Melanoma and Their Functional Roles in the Metastatic Process. | Cells | 2022 | 35159386 | PubTator, text mining | PubMed |
| Use of Omics Technologies for the Detection of Colorectal Cancer Biomarkers. | Cancers (Basel) | 2022 | 35159084 | PubTator, text mining | PubMed |
| Blood Circulating Non-Coding RNAs for the Clinical Management of Triple-Negative Breast Cancer. | Cancers (Basel) | 2022 | 35159070 | PubTator, text mining | PubMed |
| Crosstalk between Long Non Coding RNAs, microRNAs and DNA Damage Repair in Prostate Cancer: New Therapeutic Opportunities? | Cancers (Basel) | 2022 | 35159022 | PubTator, text mining | PubMed |
| Metformin as a Potential Treatment Option for Endometriosis. | Cancers (Basel) | 2022 | 35158846 | PubTator, text mining | PubMed |
| Long Non-Coding RNA in Gastric Cancer: Mechanisms and Clinical Implications for Drug Resistance. | Front Oncol | 2022 | 35155266 | PubTator, text mining | PubMed |
| Diversity of Dysregulated Long Non-Coding RNAs in HBV-Related Hepatocellular Carcinoma. | Front Immunol | 2022 | 35154157 | PubTator, text mining | PubMed |
| Identifying a Novel Defined Pyroptosis-Associated Long Noncoding RNA Signature Contributes to Predicting Prognosis and Tumor Microenvironment of Bladder Cancer. | Front Immunol | 2022 | 35154117 | PubTator, text mining | PubMed |
| Long non-coding RNA SNHG10 upregulates BIN1 to suppress the tumorigenesis and epithelial-mesenchymal transition of epithelial ovarian cancer via sponging miR-200a-3p. | Cell Death Discov | 2022 | 35149697 | PubTator, text mining | PubMed |
| Metformin inhibits pulmonary artery smooth muscle cell proliferation by upregulating p21 via NONRATT015587.2. | Int J Mol Med | 2022 | 35147202 | PubTator, text mining | PubMed |
| Regulatory Mechanism of lncRNAs in M1/M2 Macrophages Polarization in the Diseases of Different Etiology. | Front Immunol | 2022 | 35145526 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/652995/papers?page=51